Taken together, our findings reveal that the NF-κB-PKCε axis promotes tumorigenesis by upregulating glutamine metabolism and thus facilitating metabolic reprogramming to satisfy the bioenergetic and biosynthetic requirements of rapid cancer cell growth and metastasis. The gene discussed is NFKB1; the disease is cancer.